| Malignant Meningeal Neoplasm studied in …STUDIED_INderived107 of 107show fewer |
|---|
| → studied in | NCT06462222Phase 1/Phase 2 · active not recruiting Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833657Phase 2 · not yet recruiting Combined Intrathecal and Systemic Therapy With Trastuzumab Rezetecan for Leptomeningeal Metastases · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02847559Phase 2 · completed Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06762080Phase 1/Phase 2 · active not recruiting Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06809530Phase 1/Phase 2 · active not recruiting Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06557512NA · recruiting Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778940Phase 2 · not yet recruiting Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI. · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025256Phase 1 · active not recruiting Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Meningeal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06812871Phase 2 · completed High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07414979Phase 1 · not yet recruiting Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Meningeal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604978Phase 1/Phase 2 · active not recruiting Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05184816Phase 1 · recruiting A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07702305Phase 1 · not yet recruiting Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07674693Phase 1 · not yet recruiting Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03175432Phase 2 · active not recruiting Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Intracranial Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07361705Phase 1 · recruiting Zorifertinib With Osimertinib for NSCLC With Meningeal Progression · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06275919Phase 2 · recruiting Regorafenib for Recurrent Meningioma (MIRAGE Trial) · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06431685Phase 1 · recruiting Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07552233NA · recruiting NK Cell Therapy for Malignant Solid Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551414Phase 2 · not yet recruiting Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04082520Phase 2 · recruiting Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04659811Phase 2 · active not recruiting Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07348965NA · recruiting Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06984523NA · active not recruiting Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805631Phase 2 · recruiting Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04661384Phase 1 · active not recruiting Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04343573Phase 2 · completed Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04278118NA · recruiting Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study · condition mapped CURATED_BROADER · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592092NA · completed Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541082Phase 1 · recruiting Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07264569Phase 1/Phase 2 · recruiting Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001 · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01373710Phase 1/Phase 2 · completed Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02939300Phase 2 · completed Ipilimumab and Nivolumab in Leptomeningeal Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05598853Phase 1 · active not recruiting Intrathecal Double Checkpoint Inhibition · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06304441NA · recruiting Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172178early Phase 1 · not yet recruiting γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07092202Phase 4 · recruiting Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04729348Phase 2 · terminated Pembrolizumab And Lenvatinib In Leptomeningeal Metastases · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00527410Phase 1 · terminated A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06809517Phase 1/Phase 2 · recruiting Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971406Phase 2 · not yet recruiting High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05289908Phase 1/Phase 2 · completed Intrathecal Pemetrexed for Leptomeningeal Metastasis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06718972recruiting A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06926803active not recruiting A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal Metastases · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Malignant Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05746754NA · recruiting Proton Cranio-spinal Irradiation for Leptomeningeal Metastasis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06901817Phase 2 · recruiting A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05034497Phase 1 · active not recruiting Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05793034NA · recruiting Predictive Factors for Survival in Aggressive Meningiomas · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06643000NA · recruiting Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861218Phase 2 · not yet recruiting Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016091Phase 2 · terminated A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06766591NA · not yet recruiting Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06705049enrolling by invitation Retrospective Study on Leptomeningeal Metastasis of Solid Tumors · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441045Phase 2 · not yet recruiting Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434262Phase 1 · completed SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06417710recruiting Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Malignant Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019578Phase 1 · completed Stereotactic Radiosurgery in Treating Patients With Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05984108unknown Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03520504Phase 1 · completed Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05305885NA · unknown Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04315246Phase 1/Phase 2 · withdrawn 177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma) · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05385185Phase 2 · unknown Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02973256unknown Oncological Care for Patients With Meningioma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04728568NA · unknown Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04944069NA · unknown Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02255461Phase 1 · terminated Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01125046Phase 2 · completed Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01713699NA · completed Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02071056completed Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM) · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04425681Phase 2 · unknown Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04356118Phase 4 · unknown Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04356222Phase 4 · unknown Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062881Phase 1 · completed Intrathecal Mafosfamide · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Malignant Meningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03507244Phase 1/Phase 2 · completed Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04178343NA · completed Tomotherapy for Leptomeningeal Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04148898Phase 2 · unknown Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03082144Phase 2 · completed Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03101579Phase 1 · completed Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01151670Phase 1 · completed Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919750completed Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234805NA · terminated Yoga Therapy in Treating Patients With Malignant Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02607605unknown A Prospective, Observational Trial on the Diagnostic and Prognostic of LM · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045110Phase 1/Phase 2 · completed Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045734Phase 2 · completed Imatinib Mesylate in Treating Patients With Recurrent Meningioma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194452NA · withdrawn Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02967380NA · terminated Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02590510Phase 4 · unknown Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02803619unknown A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01144247Phase 1 · completed Cellular Immunotherapy Study for Brain Cancer · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326664Phase 1 · completed AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119599Phase 1 · completed RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01082926Phase 1 · completed Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946335Phase 1 · completed ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492089Phase 2 · completed Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003292Phase 2 · terminated S9624 Ifosfamide in Treating Patients With Meningeal Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01818713Phase 2 · unknown Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052780Phase 1 · completed Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063973Phase 1 · completed Cilengitide in Treating Children With Refractory Primary Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100880Phase 1 · completed Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004078Phase 2 · completed Irinotecan in Treating Children With Refractory Solid Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005812Phase 2 · terminated Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma · condition mapped PROBABILISTIC · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076530Phase 1 · completed Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053963Phase 1 · completed FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00110032Phase 1 · terminated Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Adult Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00363272Phase 1 · completed Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma · condition mapped ALIAS · 107 trials mapped (45 active) | — | — | Childhood Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01438021NA · withdrawn Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease · condition mapped ONTOLOGY_EXACT · 107 trials mapped (45 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |